Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.6, 2013-09, pp. : 775-785

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-02 ,pp. : 71-77

Bentham Science Publishers

Access to resources Recommend Favorite

The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies

Current Cancer Drug Targets, Vol. 6, Iss. 8, 2006-01 ,pp. : 671-679

Bentham Science Publishers

Access to resources Recommend Favorite

IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3042-3047

Bentham Science Publishers

Access to resources Recommend Favorite

Changes in the Expression Profile of JAK/STAT Signaling Pathway Genes and Mirnas Regulating their Expression Under the Adalimumab Therapy

Current Pharmaceutical Biotechnology, Vol. 19, Iss. 7, 2018-06 ,pp. : 556-565

Bentham Science Publishers

Access to resources Recommend Favorite

Chimeric receptors for Jak-Stat signal transduction

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 1057-1059

Informa Healthcare

Access to resources Recommend Favorite